Literature DB >> 24975574

Human interleukin-27: wide individual variation in plasma levels and complex inter-relationships with interleukin-17A.

M A Forrester1, L Robertson, N Bayoumi, B D Keavney, R N Barker, M A Vickers.   

Abstract

Although it is widely believed that interleukin (IL)-27 is anti-inflammatory, its role in controlling human immune responses is not fully established. In particular, its interactions with T helper type 17 (Th)17 cytokines are unclear. Our aims were to establish the relationships between IL-27 and proinflammatory cytokines, including IL-17A, in human sera and cultures of peripheral blood mononuclear cells. Plasma IL-27 levels in 879 healthy humans from 163 families varied widely, but with relatively low heritability (19%). Despite IL-27 including a subunit encoded by Epstein-Barr virus-induced gene 3 (EBI3), there was no correlation of levels with serological evidence of infection with the virus. Although IL-27 has been reported to inhibit IL-17A production, we demonstrated a strong positive correlation in sera, but lower correlations of IL-27 with other proinflammatory cytokines. We verified that IL-27 inhibited IL-17A production by human peripheral blood T cells in vitro, but not that it stimulated IL-10 secretion. Importantly, addition of IL-17A decreased IL-27 production by stimulated T cells but had the opposite effect on resting T cells. Together, these data suggest a model whereby IL-27 and IL-17A exerts complex reciprocal effects to boost inflammatory responses, but restrain resting cells to prevent inappropriate activation.
© 2014 British Society for Immunology.

Entities:  

Keywords:  IL-17A; IL-27; T cells; cytokines; human

Mesh:

Substances:

Year:  2014        PMID: 24975574      PMCID: PMC4233386          DOI: 10.1111/cei.12408

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  42 in total

1.  IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.

Authors:  Jifen Li; Bruno Gran; Guang-Xian Zhang; Abdolmohamad Rostami; Malek Kamoun
Journal:  J Neurol Sci       Date:  2005-05-15       Impact factor: 3.181

2.  The relation of interleukin 17 (IL-17) and IL-23 to Th1/Th2 cytokines and disease activity in systemic lupus erythematosus.

Authors:  Mo Yin Mok; Hai Jing Wu; Yi Lo; Chak Sing Lau
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

3.  Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1.

Authors:  Hong Liu; Christine Rohowsky-Kochan
Journal:  J Interferon Cytokine Res       Date:  2011-01-15       Impact factor: 2.607

Review 4.  Modulation of inflammation by interleukin-27.

Authors:  Markus Bosmann; Peter A Ward
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

5.  Serum levels of interleukin (IL)-27 in patients with ischemic heart disease.

Authors:  A Jafarzadeh; M Nemati; M T Rezayati
Journal:  Cytokine       Date:  2011-07-26       Impact factor: 3.861

6.  Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

Authors:  Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

7.  A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells.

Authors:  Amit Awasthi; Yijun Carrier; Jean P S Peron; Estelle Bettelli; Masahito Kamanaka; Richard A Flavell; Vijay K Kuchroo; Mohamed Oukka; Howard L Weiner
Journal:  Nat Immunol       Date:  2007-11-11       Impact factor: 25.606

8.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 9.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

10.  Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells.

Authors:  Marcel Batten; Noelyn M Kljavin; Ji Li; Michael J Walter; Frederic J de Sauvage; Nico Ghilardi
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

View more
  2 in total

1.  The IL-27/IL-27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients.

Authors:  Marie-Laure Clénet; Cyril Laurent; Florent Lemaitre; Negar Farzam-Kia; Olivier Tastet; Odile Devergne; Boaz Lahav; Marc Girard; Pierre Duquette; Alexandre Prat; Catherine Larochelle; Nathalie Arbour
Journal:  Clin Transl Immunology       Date:  2021-03-05

Review 2.  IL-27 regulation of innate immunity and control of microbial growth.

Authors:  Jessica M Povroznik; Cory M Robinson
Journal:  Future Sci OA       Date:  2020-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.